At least one of my questions has been answered. The anagrelide acquisition now makes sense. All this needed was timelines and this would have been a solid announcement.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025